We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
MIV Therapeutics (MIVT), a developer of next-generation biocompatible coatings
and drug delivery technologies, has executed a letter of intent to acquire Sahajanand
Medical Technologies (SMT), a manufacturer of advanced coronary stents.
St. Jude Medical has launched its first integrated pacing system analyzer (PSA)
wand, which attaches to St. Jude Medical programmers and enables clinicians
to conduct implantation testing and performance threshold testing, as well as
programming and interrogation of pacemakers, implantable cardioverter-defibrillators
(ICDs) and emerging indications devices without the need for separate analyzer
hardware.
Varian Medical Systems has received FDA 510(k) clearance for a brachytherapy
solution that enables more accurate and flexible treatment of nasopharyngeal
cancer.
BSD Medical announced that the State Food and Drug
Administration of the People's Republic of China has given regulatory approval
for the sale of the BSD-2000 in China, well in advance of BSD's initial time
projection.
Endo Pharmaceuticals said it licensed exclusive U.S. and Canadian rights to
develop and commercialize two pain-relief patches from Durect and ProEthic Pharmaceuticals.
Emergent Technologies of Austin, Texas, announced that one of its Lubbock-based
biotechs, Selenium, has agreed with Pinpoint Med, Glil Yam, Israel, to develop
an interventional catheter device which employs Selenium's patented technology.
Biophan Technologies, a developer of next-generation biomedical technology,
announced plans to begin animal trials of its advanced MRI-imageable vena cava
filter, in a research program underway at the company's newly established Biophan-Europe
division.